A doctor takes on a drug company

Article Abstract:

Apotex Inc. threatened legal action against Dr. Nancy Olivieri for violating a confidentiality agreement involving deferiprone, an experimental drug to treat thalassemia, an inherited blood disorder. Olivieri, one of the top researchers at Canada's most prestigious children's hospital, the Hospital for Sick Children, was able to secure a funding from Apotex for deferiprone. The conflict between the doctor and Apotex started when Olivieri started suspecting that the drug might be doing more harm than good. When she decided to reveal her findings, the Hospital for Sick Children did not provide her with legal help. The situation has prompted Olivieri's colleagues to ask for an inquiry about the matter.

Comment:

Threatens legal action vs Dr Nancy Olivieri for violating confidentiality deal involving experimental drug to treat thalassemia

Strategic alliances, Blood Disease Preps, Hematologic agents

---

Canadian Medical loses court case

Article Abstract:

Canadian Medical Laboratory Inc., a Mississauga, Canada-based diagnostic laboratory, has been ordered by a court to refund a C$4.5-million deposit plus accrued interests to Toronto, Canada-based private diagnostic laboratories Dynacare Inc. and Gamma North Peel Laboratory Ltd. The two companies had withdrawn from a C$90.7-million transaction to acquire Canadian Medical's businesses after Ontario's former government reduced payments to the province's private diagnostic laboratories. The judge ruled out Canadian Medical's defense that the changes in government payments in 1993 are not material adverse changes and had been expected in the industry.

Comment:

Will get, together with Dynacare Inc, C$4.5-mil deposit plus accrued interests from Canadian Medical

Legal issues & crime, Medical Laboratories, Medical and Diagnostic Laboratories, Biomedical laboratories, Canadian Medical Laboratory Inc., Dynacare Inc., Gamma North Peel Laboratories

---

Apotex loses appeal in patent-law fight with Bayer

Article Abstract:

Apotex Inc. of Toronto, Ontario, will likely pay millions of dollars in damages after losing a patent-law suit filed by German drug company Bayer AG and its Canadian division Bayer Inc. over the heart drug Nifedipine. The Ontario Court of Appeals rejected Apotex's appeal to throw out a lower court's 1995 decision and also permitted a cross-appeal filed by Bayer over the marketing of a generic form of the drug. The court ruled in favor of Bayer, deciding that the plaintiff is entitled to be awarded damages for infringement of its patent for Nifedipine.

Comment:

Co & its Canadian unit Bayer Inc win a patent-law suit against Apotex Inc over a heart drug

Patents & copyrights, Cardiovascular Preparations, Bayer AG, Cardiovascular agents

Similar abstracts:

• Abstracts: Electronic bond auction founders; US West unit chooses Merrill Lynch over firm with new system. Chicago must modernize or perish
• Abstracts: How to keep from getting hurt. Live longer, better, wiser. You can help these special athletes
• Abstracts: CAE to take at least 10 years to pay loans. Trouble in Alberta mill town highlights cross-border differences. Rumours send Midland to new high
• Abstracts: David Peterson resigns from YBM board. Fleming's bad timing caused rift with TSE board
• Abstracts: BioChem treatment for hepatitis B wins first approval for sale. St. Laurent plans $56-million overhaul of U.S. mill

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.